|
|
Office Locations:
|
55 Cambridge Parkway, Suite 401
Cambridge, MA 02142
Phone: 617-588-4900
| | |
|
|
|
- Early
- Expansion
- Growth
- Middle Market
- Seed
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Gurnet Point Capital (GPC) is a healthcare fund founded by Ernesto Bertarelli and led by Christopher A. Viehbacher. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in building a new generation of companies. Based in Cambridge, MA, its remit is global, encompassing life sciences and medical technologies. The fund invests across all stages of product development through to commercialization and does so with an approach that is a hybrid of venture and private equity investing strategies. The firm will invest in venture-stage companies with promising scientific innovations and growth- and buyout-ready opportunities with revenue and potential. Through Gurnet's venture investments, the firm will invest $500K to upwards of $20M in seed and traditional venture rounds. Through growth buyouts, Gurnet will make investments ranging from double-digit millions to $1 billion or more. Gurnet Point Capitalā€™s team brings more than 100 years of combined operational experience within life sciences and a track record of investing.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
